Evofem Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.90
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.25
|
-0.04
|
0.21
|
84.00%
|
|
2022-09-30
|
-0.25
|
-0.29
|
-0.04
|
-16.00%
|
|
2022-06-30
|
-0.98
|
-4.57
|
-3.59
|
-366.33%
|
|
2022-03-31
|
-3.00
|
-2.88
|
0.12
|
4.00%
|
|
2021-12-31
|
-3.41
|
-4.95
|
-1.54
|
-45.16%
|
|
2021-09-30
|
-4.42
|
-7.20
|
-2.78
|
-62.90%
|
|
2021-06-30
|
-5.51
|
-4.05
|
1.46
|
26.50%
|
|
2021-03-31
|
-7.31
|
-8.40
|
-1.09
|
-14.91%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-7.78
|
|
2021-12-31
|
-24.60
|
|
2020-12-31
|
-32.70
|
|
2019-12-31
|
-2.21
|
|
2018-12-31
|
-7.02
|
|
2017-12-31
|
-3.49
|
|
2016-12-31
|
-5.63
|
|
2015-12-31
|
-3.14
|
|
2014-12-31
|
-2.14
|